Gene-based blood test for melanoma may catch early signs of cancer's return

Monitoring blood levels of DNA fragments shed by dying tumor cells may accurately predict skin cancer recurrence, a new study shows.

Gene-based blood test for melanoma may catch early signs of cancer's return
Monitoring blood levels of DNA fragments shed by dying tumor cells may accurately predict skin cancer recurrence, a new study shows.